Stock News

Portland Global Advisors Has Decreased Abbott Labs (ABT) Holding by $1.31 Million; Valuation Rose; 3G Capital Partners LP Lowered Its Position in Constellation Brands (STZ) by $6.87 Million

Abbott Laboratories (NYSE:ABT) Logo

Portland Global Advisors Llc decreased its stake in Abbott Labs (ABT) by 85.37% based on its latest 2017Q4 regulatory filing with the SEC. Portland Global Advisors Llc sold 22,956 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 3,934 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $225,000, down from 26,890 at the end of the previous reported quarter. Portland Global Advisors Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $109.59B market cap company. The stock increased 1.08% or $0.67 during the last trading session, reaching $62.51. About 5.78 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 24, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

3G Capital Partners Lp decreased its stake in Constellation Brands Inc (STZ) by 10.32% based on its latest 2017Q4 regulatory filing with the SEC. 3G Capital Partners Lp sold 30,141 shares as the company’s stock declined 2.39% with the market. The hedge fund held 261,839 shares of the beverages (production and distribution) company at the end of 2017Q4, valued at $59.85M, down from 291,980 at the end of the previous reported quarter. 3G Capital Partners Lp who had been investing in Constellation Brands Inc for a number of months, seems to be less bullish one the $41.53 billion market cap company. The stock increased 0.18% or $0.38 during the last trading session, reaching $216.96. About 1.23 million shares traded. Constellation Brands, Inc. (NYSE:STZ) has risen 33.47% since May 24, 2017 and is uptrending. It has outperformed by 21.92% the S&P500.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating by BTIG Research given on Saturday, August 29. The rating was maintained by Cowen & Co on Wednesday, October 18 with “Buy”. The firm has “Buy” rating by Jefferies given on Monday, December 7. The rating was downgraded by Piper Jaffray on Thursday, April 28 to “Neutral”. The firm earned “Buy” rating on Friday, July 21 by Gabelli. As per Friday, June 16, the company rating was maintained by Jefferies. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) rating on Wednesday, January 24. BMO Capital Markets has “Buy” rating and $70.0 target. The firm has “Buy” rating given on Thursday, January 25 by Guggenheim. The rating was downgraded by Northland Capital to “Hold” on Thursday, September 28. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, January 2.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Art Lc stated it has 0.26% in Abbott Laboratories (NYSE:ABT). Shufro Rose Lc has invested 0.02% in Abbott Laboratories (NYSE:ABT). Rowland Com Investment Counsel Adv invested in 1,780 shares or 0.04% of the stock. Oakworth Cap holds 0.21% or 15,600 shares in its portfolio. Janney Montgomery Scott Llc reported 0.23% stake. Senzar Asset Management Ltd accumulated 4.48% or 307,400 shares. Cs Mckee Limited Partnership reported 382,775 shares or 1.63% of all its holdings. Cornerstone Hldgs Limited Liability Corp has invested 0.22% of its portfolio in Abbott Laboratories (NYSE:ABT). Engineers Gate Manager Ltd Partnership reported 37,026 shares stake. Roanoke Asset Mgmt New York invested in 1.35% or 49,435 shares. Bkd Wealth Ltd Company owns 9,735 shares. Van Cleef Asset Managementinc owns 12,335 shares. Bath Savings Trust invested in 0.79% or 54,991 shares. 20,814 are held by Tci Wealth Inc. Boston Family Office Ltd Llc reported 108,445 shares.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Seekingalpha.com which released: “Abbott’s stent guide improved outcomes in long-term study” on May 22, 2018, also Streetinsider.com with their article: “Abbott (ABT) Reports 5-Yr FAME 2 Study Showing Positive Outcomes of Patients Using Diagnostic Tool” published on May 22, 2018, Streetinsider.com published: “Stifel Sees Minimal Impact from Abbott Labs (ABT) HeartMate III ‘Dear Doc Letter'” on May 23, 2018. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Streetinsider.com and their article: “JPMorgan Remains Positive on Abbott (ABT), Expects Limited Impact from LVAD Recall” published on May 22, 2018 as well as Streetinsider.com‘s news article titled: “Abbott (ABT) Reports Positive Outcomes for First 100 Patients in Global Study of Investigational Tendyne Transcatheter …” with publication date: May 23, 2018.

Since December 14, 2017, it had 1 insider buy, and 21 selling transactions for $23.88 million activity. On Wednesday, January 31 the insider Blaser Brian J sold $1.73M. BIRD ROGER had sold 1,645 shares worth $96,728. $183,579 worth of Abbott Laboratories (NYSE:ABT) was sold by Watkin Jared. Fussell Stephen R sold $14.27M worth of stock or 227,412 shares. 459 shares were sold by PEDERSON MICHAEL J, worth $27,213 on Friday, February 16. Contreras Jaime sold $50,397 worth of Abbott Laboratories (NYSE:ABT) on Monday, April 23.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24 billion for 22.01 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Portland Global Advisors Llc, which manages about $321.25M and $269.69M US Long portfolio, upped its stake in Ishares Msci Eafe Index (EFA) by 5,028 shares to 276,066 shares, valued at $19.41M in 2017Q4, according to the filing.

Since January 30, 2018, it had 0 insider purchases, and 4 sales for $6.69 million activity. Another trade for 6,398 shares valued at $1.47 million was made by LOCKE JAMES A III on Tuesday, April 17. Shares for $441,943 were sold by FROMBERG BARRY A.

Among 23 analysts covering Constellation Brands (NYSE:STZ), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Constellation Brands had 83 analyst reports since August 27, 2015 according to SRatingsIntel. The company was maintained on Tuesday, April 3 by Morgan Stanley. Goldman Sachs maintained it with “Buy” rating and $180 target in Thursday, April 7 report. The rating was maintained by Wells Fargo with “Buy” on Friday, June 30. The stock of Constellation Brands, Inc. (NYSE:STZ) earned “Hold” rating by Credit Suisse on Monday, January 8. Citigroup maintained it with “Neutral” rating and $168 target in Monday, April 11 report. The stock has “Buy” rating by Goldman Sachs on Friday, June 30. As per Thursday, January 4, the company rating was maintained by Wells Fargo. The rating was initiated by Wells Fargo on Tuesday, April 5 with “Outperform”. The rating was maintained by RBC Capital Markets on Friday, November 10 with “Buy”. As per Monday, October 16, the company rating was maintained by Cowen & Co.

Analysts await Constellation Brands, Inc. (NYSE:STZ) to report earnings on July, 5. They expect $2.48 earnings per share, up 5.98% or $0.14 from last year’s $2.34 per share. STZ’s profit will be $474.72M for 21.87 P/E if the $2.48 EPS becomes a reality. After $1.90 actual earnings per share reported by Constellation Brands, Inc. for the previous quarter, Wall Street now forecasts 30.53% EPS growth.

Investors sentiment increased to 1.24 in Q4 2017. Its up 0.10, from 1.14 in 2017Q3. It improved, as 43 investors sold STZ shares while 243 reduced holdings. 97 funds opened positions while 257 raised stakes. 140.30 million shares or 2.61% less from 144.05 million shares in 2017Q3 were reported. Old Second Bankshares Of Aurora holds 1.29% or 14,276 shares in its portfolio. Wellington Management Grp Ltd Liability Partnership invested in 1.98 million shares. Silvercrest Asset Management Grp Inc Lc holds 0.03% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 15,716 shares. Metropolitan Life Insurance Ny has 0.1% invested in Constellation Brands, Inc. (NYSE:STZ). Uss reported 2.05% in Constellation Brands, Inc. (NYSE:STZ). 38 are owned by Nuwave Inv Mgmt Ltd Limited Liability Company. Wells Fargo & Com Mn has 1.55M shares. Moreover, Davenport And has 0.01% invested in Constellation Brands, Inc. (NYSE:STZ). Axel Management Limited Liability owns 22,000 shares. Lombard Odier Asset (Europe) Limited holds 0.03% or 2,077 shares in its portfolio. Gilder Gagnon Howe And Ltd Liability Corp invested 0.15% in Constellation Brands, Inc. (NYSE:STZ). Royal National Bank & Trust Of Canada has 275,296 shares. Strs Ohio accumulated 388,551 shares or 0.38% of the stock. Jane Street Grp Limited Company owns 0.17% invested in Constellation Brands, Inc. (NYSE:STZ) for 255,552 shares. First In reported 125 shares stake.

More recent Constellation Brands, Inc. (NYSE:STZ) news were published by: Nasdaq.com which released: “Constellation Brands to Present at the RBC 2018 Consumer and Retail Conference, May 30, 2018” on May 24, 2018. Also Profitconfidential.com published the news titled: “Marijuana Stocks: 3 Stocks with the Next Best Takeover Potential for Pot Giants” on May 24, 2018. Investorplace.com‘s news article titled: “20 Stocks Hedge Fund Managers Are Buying In Bulk” with publication date: May 23, 2018 was also an interesting one.

Constellation Brands, Inc. (NYSE:STZ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *